ABBOTT LABORATORIES A/S
CVR 31528615 · Public limited company (A/S) · Active · Low risk
ABBOTT LABORATORIES A/S is a Public limited company (A/S), founded on , based in København S. The company is registered in the industry engroshandel med læge- og hospitalsartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 74.4m and a net result of DKK 63.1m.
Bankruptcy risk for ABBOTT LABORATORIES A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 31528615
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (55 years)
- Address
- Arne Jacobsens Allé 13, 2.
2300 København S - Municipality
- København
- Industry
- Engroshandel med læge- og hospitalsartikler (464620)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 4.0m
- Employees
- 36 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 37.6% |
| Current ratio | 89% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 14 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 16 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 412.8m | DKK 350.4m | DKK 327.4m |
| Gross profit | DKK 66.8m | DKK 63.6m | DKK 62.6m |
| Net profit | DKK 63.1m | DKK 8.3m | DKK 9.2m |
| Equity | DKK 74.4m | DKK 141.2m | DKK 133.0m |
| Total assets | DKK 197.8m | DKK 262.6m | DKK 218.3m |
| Cash | DKK 16.5m | DKK 22.9m | – |
| Short-term debt | DKK 119.2m | DKK 118.0m | – |
| Tax owed | DKK 0 | DKK 210k | – |
| Avg. employees | 48 | 49 | – |
Latest annual report: Reporting class C, medium-size enterprise · auditor's statement: Auditor's report on audited financial statements · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 174 | ||
| 1 Jan 2024 – 31 Dec 2024 | 178 | ||
| 1 Jan 2023 – 31 Dec 2023 | 178 | ||
| 1 Jan 2022 – 31 Dec 2022 | 179 | ||
| 1 Jan 2021 – 31 Dec 2021 | 159 | ||
| 1 Jan 2020 – 31 Dec 2020 | 160 | ||
| 1 Jan 2019 – 31 Dec 2019 | 174 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 165 | ||
| 1 Jan 2016 – 31 Dec 2016 | 165 | ||
| 1 Jan 2015 – 31 Dec 2015 | 172 | ||
| 1 Jan 2014 – 31 Dec 2014 | 182 | ||
| 1 Jan 2013 – 31 Dec 2013 | 153 | ||
| 1 Jan 2012 – 31 Dec 2012 | 168 | ||
| 1 Jan 2011 – 31 Dec 2011 | 166 | ||
| 1 Dec 2009 – 30 Nov 2010 | 160 | ||
| 1 Dec 2008 – 30 Nov 2009 | 155 | ||
| 1 Dec 2007 – 30 Nov 2008 | 142 | ||
| 1 Dec 2006 – 30 Nov 2007 | 160 | ||
| 1 Dec 2005 – 30 Nov 2006 | 152 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Odd Inge Vaage-Nilsen | ||
| CEO | Mark Francis Gorman | ||
| CEO | Christer Øhlund | ||
| CEO | Ian Black | ||
| CEO | Arthur Joseph Higgins | ||
| CEO | Siegfried Brune | ||
| CEO | Henricus Adrianus Maria Lambertus van de Laar | ||
| CEO | Jean Paul Kress | ||
| CEO | Laurent Van Lerberghe | ||
| CEO | Alexander Würfel | ||
| Board | Fredrik Björn Anders Björnulfson | Current | |
| Board | Bradley Jay Slater | Current | |
| Board | Karl Andreas Almroth | Current | |
| Board | Leif Ramtung | ||
| Board | Jan-Erik Collin | ||
| Board | Christer Øhlund | ||
| Board | Thomas Richard Hodgson | ||
| Board | Jonh Duncan McIntyre | ||
| Board | Alain Joseph Marie Gilbert | ||
| Board | Mark Collier Miller | ||
| Board | Ian Black | ||
| Board | Arthur Joseph Higgins | ||
| Board | Robert Leory Parkinson, jr | ||
| Board | Gary Patrick Coughlan | ||
| Board | Ørn Reidar Stuge | ||
| Board | Siegfried Brune | ||
| Board | John Afseth | ||
| Board | Mark Francis Gorman | ||
| Board | Henricus Adrianus Maria Lambertus van de Laar | ||
| Board | Jean Paul Kress | ||
| Board | Thomas Craig Freyman | ||
| Board | Kate Tørnø | ||
| Board | Laurent Van Lerberghe | ||
| Board | Alexander Würfel | ||
| Board | Tom Schjødt | ||
| Board | Christina Dyreborg Jeppesen | ||
| Board | Erik Hjalmar Björkman | ||
| Board | Palle Michael Christensen | ||
| Board | Jorun Klokk Holst | ||
| Board | Brian B. Yoor | ||
| Board | Peter Frønsdal Toft | ||
| Board | Ole Martin Alfstad Christiansen | ||
| Board | Benjamin Edward Oosterbaan | ||
| Owner (100%) | ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED | Current | |
| Owner (100%) | Abbott Investments Luxembourg S.à r.l. | ||
| Owner (100%) | St. Jude Medical International Holding | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | ANDERSEN STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB |
The CEOs' other companies
Odd Inge Vaage-Nilsen – 4 other companies
- BECH LAURSEN & CO. ApS Opløst
- OCTAVIUS ApS Active
- PHARMACOSMOS A/S Active
- PHARMACOSMOS A/S Fusioneret
Mark Francis Gorman – 1 other companies
- MEDISENSE DANMARK A/S Fusioneret
Henricus Adrianus Maria Lambertus van de Laar – 1 other companies
- MEDISENSE DANMARK A/S Fusioneret
Address history (4 moves)
| Arne Jacobsens Allé 13, 2., 2300 København S | |
| Produktionsvej 14, 2600 Glostrup | |
| Emdrupvej 28C, 2100 København Ø | |
| Emdrupvej 28 c, 2100 København Ø | |
| Smakkedalen 6, 2820 Gentofte |
Employees per year
Other companies at the same address
- Abbott Rapid Diagnostics A/S Active
- BAYER A/S Active
- DIBS PAYMENT SERVICES A/S Fusioneret
- KLP EJENDOMME A/S Active
- KLP Sundkrogsgade 7-9 ApS Active
- KLP TEGLHOLMSGADE 1-3 A/S Active
- KLP Weidekampsgade 6 A/S Active
- KLP ØRESTAD 5G A/S Active
- KLP ØSTERGADE 8-12 A/S Active
- Komplementar KLP Gærtorvet 1-5 ApS Active
- København Sydhavn ApS Active
- MEDRAD DENMARK ApS Fusioneret
- MONSANTO CROP SCIENCES DENMARK A/S Fusioneret
- Mastercard OB Services Europe A/S Active
- Mastercard Payment Services Denmark A/S Active
- NORDIC RESIDENTIAL PROPERTIES A/S Active
Similar companies in København
- Kaliber ApS Valby
- Reinsberg Group Nordic ApS København K
- ResQ NXT ApS København K
- Steripolar ApS København K
- NB DENTAL APS Valby
- MiniMed Denmark ApS Nordhavn
- MILA International Europe A/S København V
- ATECH HEALTH ApS København K
- Vitestro Denmark ApS København Ø
- CosmoLight ApS København SV
- Rheia Medical ApS København N
- Copenhagen Medical Cryo ApS København Ø
Questions and answers about ABBOTT LABORATORIES A/S
Has ABBOTT LABORATORIES A/S gone bankrupt?
No, ABBOTT LABORATORIES A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ABBOTT LABORATORIES A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of ABBOTT LABORATORIES A/S?
ABBOTT LABORATORIES A/S most recently used EY Godkendt Revisionspartnerselskab.
When was ABBOTT LABORATORIES A/S founded?
ABBOTT LABORATORIES A/S was founded on 4 February 1971.
What is the equity of ABBOTT LABORATORIES A/S?
Equity was DKK 74.4m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.